Advertisement
Screener

PFIZER INC (PFE) Investment Income, Interest

PFIZER INC Investment Income, Interest

PFIZER INC (PFE) reported Investment Income, Interest of $113.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Other Income

us-gaap:InvestmentIncomeInterest · last filed 2026-08-04

  • PFIZER INC investment income, interest for the quarter ending 2026-06-28 was $113.00M, a 27.56% decline year-over-year.
  • PFIZER INC investment income, interest for the quarter ending 2026-03-29 was $115.00M, a 19.58% decline year-over-year.
  • PFIZER INC investment income, interest for the quarter ending 2025-12-31 was $166.00M, a 2.92% decline year-over-year.
  • PFIZER INC investment income, interest for the quarter ending 2025-09-28 was $138.00M, a 18.97% increase year-over-year.
  • PFIZER INC investment income, interest for fiscal 2025 was $603.00M, a 10.64% increase from fiscal 2024.
  • PFIZER INC investment income, interest for fiscal 2024 was $545.00M, a 66.44% decline from fiscal 2023.
  • PFIZER INC investment income, interest for fiscal 2023 was $1.62B, a 547.01% increase from fiscal 2022.
  • PFIZER INC investment income, interest for fiscal 2022 was $251.00M, a 597.22% increase from fiscal 2021.
Period endInvestment Income, Interest 3 monthInvestment Income, Interest 3 month as first filedInvestment Income, Interest 6 monthInvestment Income, Interest 9 monthInvestment Income, Interest 9 month as first filedInvestment Income, Interest 12 monthInvestment Income, Interest 12 month as first filed
2026-06-28$113.00M
10-Q · filed 2026-08-04
$228.00M
10-Q · filed 2026-08-04
$394.00M
derived: sum of 3 quarters · filed 2026-08-04
$532.00M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-29$115.00M
10-Q · filed 2026-05-05
$281.00M
derived: sum of 2 quarters · filed 2026-05-05
$419.00M
derived: sum of 3 quarters · filed 2026-05-05
$575.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$166.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$304.00M
derived: sum of 2 quarters · filed 2026-02-26
$460.00M
derived: sum of 3 quarters · filed 2026-08-04
$603.00M
10-K · filed 2026-02-26
2025-09-28$138.00M
10-Q · filed 2025-11-04
$294.00M
derived: sum of 2 quarters · filed 2026-08-04
$437.00M
10-Q · filed 2025-11-04
$608.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-29$156.00M
10-Q · filed 2026-08-04
$299.00M
10-Q · filed 2026-08-04
$470.00M
derived: sum of 3 quarters · filed 2026-08-04
$586.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-30$143.00M
10-Q · filed 2026-05-05
$314.00M
derived: sum of 2 quarters · filed 2026-05-05
$430.00M
derived: sum of 3 quarters · filed 2026-05-05
$560.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$171.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$287.00M
derived: sum of 2 quarters · filed 2026-02-26
$417.00M
derived: sum of 3 quarters · filed 2026-02-26
$545.00M
10-K · filed 2026-02-26
2024-09-29$116.00M
10-Q · filed 2025-11-04
$246.00M
derived: sum of 2 quarters · filed 2025-11-04
$374.00M
10-Q · filed 2025-11-04
$984.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$130.00M
10-Q · filed 2025-08-05
$259.00M
10-Q · filed 2025-08-05
$868.00M
derived: sum of 3 quarters · filed 2026-02-26
$1.39B
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$129.00M
10-Q · filed 2025-05-05
$738.00M
derived: sum of 2 quarters · filed 2026-02-26
$1.26B
derived: sum of 3 quarters · filed 2026-02-26
$1.58B
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$609.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$1.13B
derived: sum of 2 quarters · filed 2026-02-26
$1.45B
derived: sum of 3 quarters · filed 2026-02-26
$1.62B
10-K · filed 2026-02-26
2023-10-01$523.00M
10-Q · filed 2024-11-04
$839.00M
derived: sum of 2 quarters · filed 2024-11-04
$1.01B
10-Q · filed 2024-11-04
$1.15B
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$316.00M
10-Q · filed 2024-08-05
$493.00M
10-Q · filed 2024-08-05
$630.00M
derived: sum of 3 quarters · filed 2025-02-27
$700.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02$177.00M
10-Q · filed 2024-05-08
$314.00M
derived: sum of 2 quarters · filed 2025-02-27
$384.00M
derived: sum of 3 quarters · filed 2025-02-27
$414.00M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$137.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$207.00M
derived: sum of 2 quarters · filed 2025-02-27
$237.00M
derived: sum of 3 quarters · filed 2025-02-27
$251.00M
10-K · filed 2025-02-27
2022-10-02$70.00M
10-Q · filed 2023-11-08
$100.00M
derived: sum of 2 quarters · filed 2023-11-08
$114.00M
10-Q · filed 2023-11-08
$129.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-07-03$30.00M
10-Q · filed 2023-08-09
$44.00M
10-Q · filed 2023-08-09
$59.00M
derived: sum of 3 quarters · filed 2024-02-22
$69.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-04-03$14.00M
10-Q · filed 2023-05-10
$29.00M
derived: sum of 2 quarters · filed 2024-02-22
$39.00M
derived: sum of 3 quarters · filed 2024-02-22
$52.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$25.00M
derived: sum of 2 quarters · filed 2024-02-22
$38.00M
derived: sum of 3 quarters · filed 2024-02-22
$36.00M
10-K · filed 2024-02-22
2021-10-03$10.00M
10-Q · filed 2022-11-09
$23.00M
derived: sum of 2 quarters · filed 2022-11-09
$21.00M
10-Q · filed 2022-11-09
$28.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04$13.00M
10-Q · filed 2022-08-10
$12.00M
10-Q · filed 2022-08-10
$18.00M
derived: sum of 3 quarters · filed 2023-02-23
$33.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-04-04$0.00
10-Q · filed 2022-05-11
$5.00M
derived: sum of 2 quarters · filed 2023-02-23
$20.00M
derived: sum of 3 quarters · filed 2023-02-23
$39.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$20.00M
derived: sum of 2 quarters · filed 2023-02-23
$39.00M
derived: sum of 3 quarters · filed 2023-02-23
$73.00M
10-K · filed 2023-02-23
2020-09-27$15.00M
10-Q · filed 2021-11-12
$17.00M
10-Q · filed 2020-11-05
$34.00M
derived: sum of 2 quarters · filed 2021-11-12
$68.00M
10-Q · filed 2021-11-12
$70.00M
10-Q · filed 2020-11-05
$108.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-28$19.00M
10-Q · filed 2021-08-12
$53.00M
10-Q · filed 2021-08-12
$93.00M
derived: sum of 3 quarters · filed 2022-02-24
$153.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-29$34.00M
10-Q · filed 2021-05-13
$74.00M
derived: sum of 2 quarters · filed 2022-02-24
$134.00M
derived: sum of 3 quarters · filed 2022-02-24
$193.00M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$40.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$100.00M
derived: sum of 2 quarters · filed 2022-02-24
$159.00M
derived: sum of 3 quarters · filed 2022-02-24
$225.00M
10-K · filed 2022-02-24
$226.00M
10-K · filed 2020-02-27
2019-09-29$60.00M
10-Q · filed 2020-11-05
$119.00M
derived: sum of 2 quarters · filed 2020-11-05
$185.00M
10-Q · filed 2020-11-05
$278.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$59.00M
10-Q · filed 2020-08-06
$125.00M
10-Q · filed 2020-08-06
$218.00M
derived: sum of 3 quarters · filed 2021-02-25
$300.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$66.00M
10-Q · filed 2020-05-07
$159.00M
derived: sum of 2 quarters · filed 2021-02-25
$241.00M
derived: sum of 3 quarters · filed 2021-02-25
$321.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$93.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$175.00M
derived: sum of 2 quarters · filed 2021-02-25
$255.00M
derived: sum of 3 quarters · filed 2021-02-25
$333.00M
10-K · filed 2021-02-25
2018-09-30$82.00M
10-Q · filed 2019-11-07
$162.00M
derived: sum of 2 quarters · filed 2019-11-07
$240.00M
10-Q · filed 2019-11-07
$355.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01$80.00M
10-Q · filed 2019-08-08
$157.00M
10-Q · filed 2019-08-08
$273.00M
derived: sum of 3 quarters · filed 2020-02-27
$372.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01$77.00M
10-Q · filed 2019-05-09
$193.00M
derived: sum of 2 quarters · filed 2020-02-27
$292.00M
derived: sum of 3 quarters · filed 2020-02-27
$386.00M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$116.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$215.00M
derived: sum of 2 quarters · filed 2020-02-27
$309.00M
derived: sum of 3 quarters · filed 2020-02-27
$391.00M
10-K · filed 2020-02-27
2017-10-01$99.00M
10-Q · filed 2018-11-08
$193.00M
derived: sum of 2 quarters · filed 2018-11-08
$275.00M
10-Q · filed 2018-11-08
$387.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02$94.00M
10-Q · filed 2018-08-09
$175.00M
10-Q · filed 2018-08-09
$288.00M
derived: sum of 3 quarters · filed 2019-02-28
$411.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02$81.00M
10-Q · filed 2018-05-10
$194.00M
derived: sum of 2 quarters · filed 2019-02-28
$317.00M
derived: sum of 3 quarters · filed 2019-02-28
$439.00M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$113.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$236.00M
derived: sum of 2 quarters · filed 2019-02-28
$358.00M
derived: sum of 3 quarters · filed 2019-02-28
$470.00M
10-K · filed 2019-02-28
2016-10-02$123.00M
10-Q · filed 2017-11-09
$245.00M
derived: sum of 2 quarters · filed 2017-11-09
$357.00M
10-Q · filed 2017-11-09
$497.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-07-03$122.00M
10-Q · filed 2017-08-10
$234.00M
10-Q · filed 2017-08-10
$374.00M
derived: sum of 3 quarters · filed 2018-02-22
$495.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-04-03$113.00M
10-Q · filed 2017-05-11
$252.00M
derived: sum of 2 quarters · filed 2018-02-22
$373.00M
derived: sum of 3 quarters · filed 2018-02-22
$492.00M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$139.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$260.00M
derived: sum of 2 quarters · filed 2018-02-22
$379.00M
derived: sum of 3 quarters · filed 2018-02-22
$471.00M
10-K · filed 2018-02-22
2015-09-27$121.00M
10-Q · filed 2016-11-10
$240.00M
derived: sum of 2 quarters · filed 2016-11-10
$332.00M
10-Q · filed 2016-11-10
$455.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-28$119.00M
10-Q · filed 2016-08-11
$211.00M
10-Q · filed 2016-08-11
$334.00M
derived: sum of 3 quarters · filed 2017-02-23
$442.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-29$93.00M
10-Q · filed 2016-05-12
$215.00M
derived: sum of 2 quarters · filed 2017-02-23
$323.00M
derived: sum of 3 quarters · filed 2017-02-23
$427.00M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$122.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$230.00M
derived: sum of 2 quarters · filed 2017-02-23
$334.00M
derived: sum of 3 quarters · filed 2017-02-23
$425.00M
10-K · filed 2017-02-23
2014-09-28$108.00M
10-Q · filed 2015-11-05
$212.00M
derived: sum of 2 quarters · filed 2015-11-05
$303.00M
10-Q · filed 2015-11-05
$416.00M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-29$104.00M
10-Q · filed 2015-08-06
$196.00M
10-Q · filed 2015-08-06
$308.00M
derived: sum of 3 quarters · filed 2016-02-29
$402.00M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-30$92.00M
10-Q · filed 2015-05-07
$204.00M
derived: sum of 2 quarters · filed 2016-02-29
$298.00M
derived: sum of 3 quarters · filed 2016-02-29
2013-12-31$112.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$206.00M
derived: sum of 2 quarters · filed 2016-02-29
$403.00M
10-K · filed 2016-02-29
2013-09-29$94.00M
10-Q · filed 2014-11-06
$291.00M
10-Q · filed 2014-11-06
2012-12-31$382.00M
10-K · filed 2015-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64